Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Yan

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejectionQin Ning, Yi Sun, Meifang Han, et al.
Nature Communications|December 5, 2024
Optimizing cover crop practices as a sustainable solution for global agroecosystem servicesTianyi Qiu, Yu Shi, Josep Peñuelas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 10, 2026
FGL2-HDAC11 Drives Immunothrombosis via NETs-Mediated Endothelial Capillarization in MASLD FibrosisXitang Li, Junjian Hu, Suping Hai, et al.
Hepatology International|June 8, 2019
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor studyDi Wu, Peng Wang, Meifang Han, et al.
Journal of Medical Virology|August 25, 2023
Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, ChinaCong Fang, Weiming Yan, Yuying Chen, et al.
BMJ (Clinical Research Ed.)|March 29, 2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective studyTao Chen, Di Wu, Huilong Chen, et al.
Hepatology International|October 7, 2020
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, ChinaMing Wang, Weiming Yan, Weipeng Qi, et al.
Hepatology International|December 9, 2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trialDi Wu, Da Huang, Shifang Peng, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Development and validation of a novel mortality risk stratification simplified scoring scale for severe fever with thrombocytopenia syndromeTao Chen, Meng Zhang, Qian Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2021
Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, ChinaTingting Liu, Di Wu, Weiming Yan, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejectionQin Ning, Yi Sun, Meifang Han, et al.
Nature Communications|December 5, 2024
Optimizing cover crop practices as a sustainable solution for global agroecosystem servicesTianyi Qiu, Yu Shi, Josep Peñuelas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 10, 2026
FGL2-HDAC11 Drives Immunothrombosis via NETs-Mediated Endothelial Capillarization in MASLD FibrosisXitang Li, Junjian Hu, Suping Hai, et al.
Hepatology International|June 8, 2019
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor studyDi Wu, Peng Wang, Meifang Han, et al.
Journal of Medical Virology|August 25, 2023
Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, ChinaCong Fang, Weiming Yan, Yuying Chen, et al.
BMJ (Clinical Research Ed.)|March 29, 2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective studyTao Chen, Di Wu, Huilong Chen, et al.
Hepatology International|October 7, 2020
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, ChinaMing Wang, Weiming Yan, Weipeng Qi, et al.
Hepatology International|December 9, 2025
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trialDi Wu, Da Huang, Shifang Peng, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Development and validation of a novel mortality risk stratification simplified scoring scale for severe fever with thrombocytopenia syndromeTao Chen, Meng Zhang, Qian Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2021
Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, ChinaTingting Liu, Di Wu, Weiming Yan, et al.
Pageof 13